Aim: Minimally invasive distal pancreatectomy has become the standard of care for benign and low malignant lesions. Spleen preservation in this setting has been proposed to reduce surgical trauma and long-term sequelae. The aim of the current study is to present real-world data on indications, techniques, and outcomes of spleen-preserving distal pancreatectomy (SPDP). Methods: Patients who underwent SPDP and distal pancreatectomy with splenectomy (DPWS) were extracted from the 2019-2022 Italian National Registry for Minimally Invasive Pancreatic Surgery (IGoMIPS). Perioperative and pathological data were collected. Results: One hundred and ten patients underwent SPDP and five hundred and seventy-eight underwent DPWS. Patients undergoing SPDP were significantly younger (56 vs. 63.5 years; P < 0.001). Seventy-six percent of SPDP cases were performed in six out of thirty-four IGoMIPS centers. SPDP was performed predominantly for Neuroendocrine Tumors (43.6% vs.23.5%; P < 0.001) and for smaller lesions (T1 57.6% vs. 29.8%; P < 0.001). The conversion rate was higher in the case of DPWS (7.6% vs. 0.9%; P = 0.006), even when pancreatic cancer was ruled out (5.0% vs. 0.9%; P = 0.045). The robotic approach was most commonly used for SPDP (50.9% vs. 29.7%; P < 0.001). No difference in postoperative outcomes and length of stay was observed between the two groups, as well as between robotic and laparoscopic approaches in the SPDP group. A trend toward a lower rate of postoperative sepsis was observed after SPDP (0.9% vs. 5.2%; P = 0.056). In 84.7% of SPDP, splenic vessels were preserved (Kimura procedure) without an impact on short-term postoperative outcomes. Conclusion: In this registry analysis, SPDP was feasible and safe. The Kimura procedure was prevalent over the Warshaw procedure. The typical patient undergoing SPDP was young with a neuroendocrine tumor at an early stage. Robotic assistance was used more frequently for SPDP than for DPWS.

Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) / Donisi G.; Capretti G.; Napoli N.; Partelli S.; Esposito A.; Ferrari G.; Butturini G.; Morelli L.; Hilal M.A.; Viola M.; Benedetto F.D.; Troisi R.; Vivarelli M.; Jovine E.; Caputo D.; Ferrero A.; Bracale U.; Alfieri S.; Casadei R.; Ercolani G.; Moraldi L.; Molino C.; Valle R.D.; Ettorre G.; Memeo R.; Zanus G.; Belli A.; Gruttadauria S.; Brolese A.; Coratti A.; Garulli G.; Romagnoli R.; Massani M.; Belli G.; Falconi M.; Salvia R.; Boggi U.; Zerbi A.. - In: MINI-INVASIVE SURGERY. - ISSN 2574-1225. - ELETTRONICO. - 7:(2023), pp. 20-31. [10.20517/2574-1225.2022.92]

Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS)

Capretti G.;Troisi R.;Jovine E.;Ercolani G.;Molino C.;Belli A.;Garulli G.;Massani M.;
2023

Abstract

Aim: Minimally invasive distal pancreatectomy has become the standard of care for benign and low malignant lesions. Spleen preservation in this setting has been proposed to reduce surgical trauma and long-term sequelae. The aim of the current study is to present real-world data on indications, techniques, and outcomes of spleen-preserving distal pancreatectomy (SPDP). Methods: Patients who underwent SPDP and distal pancreatectomy with splenectomy (DPWS) were extracted from the 2019-2022 Italian National Registry for Minimally Invasive Pancreatic Surgery (IGoMIPS). Perioperative and pathological data were collected. Results: One hundred and ten patients underwent SPDP and five hundred and seventy-eight underwent DPWS. Patients undergoing SPDP were significantly younger (56 vs. 63.5 years; P < 0.001). Seventy-six percent of SPDP cases were performed in six out of thirty-four IGoMIPS centers. SPDP was performed predominantly for Neuroendocrine Tumors (43.6% vs.23.5%; P < 0.001) and for smaller lesions (T1 57.6% vs. 29.8%; P < 0.001). The conversion rate was higher in the case of DPWS (7.6% vs. 0.9%; P = 0.006), even when pancreatic cancer was ruled out (5.0% vs. 0.9%; P = 0.045). The robotic approach was most commonly used for SPDP (50.9% vs. 29.7%; P < 0.001). No difference in postoperative outcomes and length of stay was observed between the two groups, as well as between robotic and laparoscopic approaches in the SPDP group. A trend toward a lower rate of postoperative sepsis was observed after SPDP (0.9% vs. 5.2%; P = 0.056). In 84.7% of SPDP, splenic vessels were preserved (Kimura procedure) without an impact on short-term postoperative outcomes. Conclusion: In this registry analysis, SPDP was feasible and safe. The Kimura procedure was prevalent over the Warshaw procedure. The typical patient undergoing SPDP was young with a neuroendocrine tumor at an early stage. Robotic assistance was used more frequently for SPDP than for DPWS.
2023
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) / Donisi G.; Capretti G.; Napoli N.; Partelli S.; Esposito A.; Ferrari G.; Butturini G.; Morelli L.; Hilal M.A.; Viola M.; Benedetto F.D.; Troisi R.; Vivarelli M.; Jovine E.; Caputo D.; Ferrero A.; Bracale U.; Alfieri S.; Casadei R.; Ercolani G.; Moraldi L.; Molino C.; Valle R.D.; Ettorre G.; Memeo R.; Zanus G.; Belli A.; Gruttadauria S.; Brolese A.; Coratti A.; Garulli G.; Romagnoli R.; Massani M.; Belli G.; Falconi M.; Salvia R.; Boggi U.; Zerbi A.. - In: MINI-INVASIVE SURGERY. - ISSN 2574-1225. - ELETTRONICO. - 7:(2023), pp. 20-31. [10.20517/2574-1225.2022.92]
Donisi G.; Capretti G.; Napoli N.; Partelli S.; Esposito A.; Ferrari G.; Butturini G.; Morelli L.; Hilal M.A.; Viola M.; Benedetto F.D.; Troisi R.; Vivarelli M.; Jovine E.; Caputo D.; Ferrero A.; Bracale U.; Alfieri S.; Casadei R.; Ercolani G.; Moraldi L.; Molino C.; Valle R.D.; Ettorre G.; Memeo R.; Zanus G.; Belli A.; Gruttadauria S.; Brolese A.; Coratti A.; Garulli G.; Romagnoli R.; Massani M.; Belli G.; Falconi M.; Salvia R.; Boggi U.; Zerbi A.
File in questo prodotto:
File Dimensione Formato  
Dionisi_2023.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 717.04 kB
Formato Adobe PDF
717.04 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/961964
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact